Average Co-Inventor Count = 2.22
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Riboscience LLC (10 from 12 patents)
2. Janssen Sciences Ireland Unlimited Company (2 from 60 patents)
3. Novira Therapeutics, Inc. (2 from 44 patents)
12 patents:
1. 12029744 - Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors
2. 11351186 - 4'-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
3. 11129834 - Combinations and methods comprising a capsid assembly inhibitor
4. 10953030 - 4'-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
5. 10682369 - 4'-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
6. 10441589 - Combinations and methods comprising a capsid assembly inhibitor
7. 10358458 - 4'-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication
8. 10092649 - 4'-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication
9. 9895442 - 4'-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
10. 9694028 - 4'-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication
11. 9370569 - 4'-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication
12. 9249176 - 4'-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication